12 | $MBRX News Article - Biotech Brief: Optimistic | whytestocks | 04/23/2019 8:45:40 AM |
11 | MBRX 168% v82,4M c2.98 f29M H 3.19 not looking | znewcar1 | 04/22/2019 4:57:21 PM |
10 | $MBRX News Article - MBRX Stock Up 150% on | whytestocks | 04/22/2019 4:15:40 PM |
9 | $MBRX News Article - Biotech Brief: FDA Fast | whytestocks | 04/18/2019 8:25:39 AM |
8 | $MBRX News Article - Moleculin Receives FDA | whytestocks | 04/18/2019 8:05:43 AM |
7 | $MBRX News Article - Moleculin Announces | whytestocks | 04/17/2019 10:10:41 AM |
6 | $MBRX News Article - Moleculin Announces | whytestocks | 04/09/2019 8:45:40 AM |
5 | MBRX 10% v881K c.8933 f29M here is a blast from | znewcar1 | 04/01/2019 6:17:12 PM |
4 | $MBRX News Article - Cancer Biology Clinical ![]() |
whytestocks | 03/26/2019 10:35:42 AM |
3 | $MBRX News Article - Moleculin Announces First | whytestocks | 03/19/2019 12:15:41 PM |
2 | $MBRX staging $2.55 Nasdaq | PoemStone | 09/03/2017 9:52:52 AM |
1 | $MBRX at breakout $2.98 | PoemStone | 08/10/2017 5:29:10 PM |
Recent Articles
- Eagle Pharmaceuticals Shares First Quarter Financial Overview
- Verde AgriTech Unveils Major Rare Earth Discovery in Brazil
- Fortinet Investors Urged to Act Amidst Class Action Lawsuit
- Incredible Growth of First BanCorp: A Decade of Investment Success
- Understanding the KinderCare Learning Companies Class Action
- Mesoblast's Ryoncil Sales Surge with Impressive Growth
- Join the Fight for Justice with Spirit Aviation Holdings, Inc.
- Qualtrics' Bold Move to Transform Experience Management with Forsta
- Mesoblast's Ryoncil® Achieves Remarkable Revenue Growth
- Investing in Growth: An Insight into GMO’s DRES ETF
- FLYE Investors Face Securities Fraud Lawsuit Opportunity
- KBR, Inc. Shareholders Urged to Act on Class Action Case
- Understanding the Class Action Against Jasper Therapeutics and JSPR
- Fortinet, Inc. Class Action Update: Important Investor Insights
- LuxUrban Securities Case: Key Allegations Dismissed by Court
- AEG Europe Leads the Charge in Sustainable Power for UK Venues
- Qualigen Therapeutics Strengthens Leadership with Key Appointments
- Legal Counsel Alert for Unicycive Therapeutics Inc. Investors
- Transforming $100 Into $670: The InterDigital Investment Journey
- Cytokinetics Inc. Investors Get Ready for Lead Plaintiff Deadline
- Understanding the Spirit Aviation Holdings Class Action Lawsuit
- Investors Take Note: Class Action Against Quanex Building Products
- Investors Alert: Class Action Against RCI Hospitality Holdings
- A Five-Year Investment Journey with Citigroup Stock
- Key Updates on Charter Communications' Class Action Lawsuit
- Investigation Launched into Edwards Lifesciences' Leadership
- Exclusive MILITARY STAR Offer: Enjoy 3-Month 0% Interest!
- Dyne Therapeutics Reveals Promising Data from DM1 Trial
- AlphaGen Intelligence Corp. Enhances Financial Strategy through Debt Settlement
- Earnings Release and Call for Park Aerospace Corp. Update
- The Incredible Growth of Eli Lilly: A 10-Year Journey
- Interfor Set to Reveal Q3 Financial Insights on November 6
- Remarkable Growth: Planet Fitness Stock Over a Decade
- AlphaGen Intelligence Corp. Advances Financial Strategy through Debt Settlement
- HLJ Foam Expands Horizons with Arlee Home Fashions Partnership
- Dallas College Chancellor Drives Global Impact Through Education
- Bombardier Executes Full and Partial Redemption of Senior Notes
- Interfor Corporation to Release Q3 Financial Results Soon
- Bombardier's Strategic Financial Moves: Complete and Partial Notes Redemption
- Explore Incredible Savings on Philips Monitors Graphics
- W.T.B. Financial Corporation Expands Share Buyback Program
- AOC Gaming Unveils Exciting Savings on Top Gaming Monitors
- K-Diamonds and KPOP DAO Launch Revolutionary K-Culture Platform
- Billor Launches Innovative Headquarters in Raleigh
- Dyne Therapeutics Reveals Promising One-Year Findings in DM1 Study
- Understanding the Class Action Lawsuit Against Dow Inc.
- SPX Technologies Anticipates Third Quarter Financial Update
- Trilogy Metals Gains Major Support from U.S. Investment
- Upcoming Earnings Release and Insights from Park Aerospace Corp.
- PrairieSky Royalty Set to Discuss Q3 2025 Financial Results